AUL: Difference between revisions
From haematologyetc.co.uk
No edit summary |
No edit summary |
||
Line 13: | Line 13: | ||
{| class="wikitable" style="color:black; background-color:#ffffff;" cellpadding="0" | {| class="wikitable" style="color:black; background-color:#ffffff;" cellpadding="0" | ||
!colspan="2" <span style="font-size:90%; font-color:navy; style="text-align: left; border: 1px solid black; background:pale gray">|'''What features must be met to diagnose acute undifferentiated leukaemia'''</br></span> | !colspan="2" <span style="font-size:90%; font-color:navy; style="text-align: left; border: 1px solid black; background:pale gray">|'''What features must be met to diagnose acute undifferentiated leukaemia'''</br></span> | ||
|- | |- | ||
|colspan="2" style = "font-size:90%; color:black; background:#ddeee1" |'''Requirement 1''' | |colspan="2" style = "font-size:90%; color:black; background:#ddeee1" |'''Requirement 1''' |
Revision as of 22:48, 21 December 2023
.
What features must be met to diagnose acute undifferentiated leukaemia | |
---|---|
Requirement 1 | |
No lineage can be assigned by lineage-defining markers of myeloid, B-lymphoid or T-lymphoid lineage | |
Requirement 2 | |
No more than one lineage-associated marker for any single lineage is expressed | |
Requirement 3 | |
Ensure that other conditions that may resemble undifferentiated acute leukaemia are excluded: particularly consider: acute megakaryocytic leukaemia, non haematopoietic tumours, blastic plasma dendritic cell neoplasm, and rarely plasma cell leukaemias. |